Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients. [electronic resource]
- Transplant infectious disease : an official journal of the Transplantation Society Feb 2019
- e13015 p. digital
Publication Type: Journal Article
1399-3062
10.1111/tid.13015 doi
Adult Aged Antiviral Agents--therapeutic use Cytomegalovirus--isolation & purification Cytomegalovirus Infections--blood Female Follow-Up Studies Ganciclovir--therapeutic use Graft Survival Heart Diseases--blood Heart Transplantation--adverse effects Humans Male Middle Aged Prospective Studies Retrospective Studies Risk Assessment Serologic Tests Survival Analysis Tissue Donors--statistics & numerical data Transplant Recipients--statistics & numerical data Valganciclovir--therapeutic use Young Adult